ApoGraft
Phase 1/2- Indications
- Hematological malignancies, Graft versus host disease
Company intelligence / Profile preview
Lacrima Medical has developed a disposable medical device that applies constant light pressure to the medial palpebral ligament to induce sleep. The treatment is drug-free, self-administered, and cost-effective. No published clinical trial results were found in the provided sources.[1][2]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lacrima Medical.